Infectious molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination
about
A single polymorphism in HIV-1 subtype C SP1 is sufficient to confer natural resistance to the maturation inhibitor bevirimatVaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protectionGeneration of recombinant vaccinia viruses via green fluorescent protein selectionNeutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.Dynamics of envelope evolution in clade C SHIV-infected pig-tailed macaques during disease progression analyzed by ultra-deep pyrosequencing.Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcriptionIsolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120.Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges.Bimodal AIDS vaccine approach: induction of cellular as well as humoral immunity can protect from systemic infection.Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy.Construction of a high titer infectious HIV-1 subtype C proviral clone from South Africa.Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding SitesExceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity.High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure: prevention of viremiaPathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virusLong-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cellsStability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.The 57th amino acid conveys the differential subcellular localization of human immunodeficiency virus-1 Tat derived from subtype B and C.Mucosal IgA Responses: Damaged in Established HIV Infection-Yet, Effective Weapon against HIV Transmission.A novel strategy to adapt SHIV-E1 carrying env from an RV144 volunteer to rhesus macaques: coreceptor switch and final recovery of a pathogenic virus with exclusive R5 tropism.
P2860
Q24606079-50CF02A7-28B1-4716-96F6-151565A64D3FQ27332360-28666102-6D0D-459A-8F20-0B522099FBB4Q30857503-8B4C755C-E899-41FE-9FF4-33E9A0EB8BA4Q33382060-8F8DDC45-1FD8-4FCF-B2A6-23A05A24A4C2Q34200095-4017FC87-2FC3-49F0-8D24-278BC5F16DFCQ34243467-0294CE30-B01F-4A11-AECA-01DCD0251EE8Q34596398-8B107F72-69C3-48FD-9360-C88070F833E0Q34885869-2421ECF5-8099-4447-9C7B-72F53206721CQ35129224-69E85524-B2D8-4209-BCB0-0765AF0F63BCQ35160124-C595D201-5341-4ED6-A375-3599F17B793EQ35198510-ABE9E2C5-D7B9-4829-9437-E249D34D2069Q35734891-836C57A0-85FB-4DE6-BA07-EE07517514A5Q36404211-7DD241E9-CCEE-4AB7-BA41-2AC6604683F3Q36434294-543B8C92-40FB-4881-9357-926EA254C507Q36539298-417CFBFB-19E4-43E7-A01B-CC447FCF8336Q36940756-C5827226-2354-4BF3-9D1D-FBA66232354BQ37032195-BAE58766-DD67-4FA0-A362-A64B91DE0706Q37157729-915B23F4-6EB4-496F-AA09-AE15DE996161Q37287933-B5BF3AFA-DF82-4A29-87AD-94B549411D1EQ40726557-488BAA42-B338-44CB-8D77-D6743FF13BA0Q40743714-26FC2A9E-6F0B-47D8-ABF8-5859213E1D32Q40809992-7250D297-F5DD-40BC-97C8-5393E4DF917BQ45438864-5C77EB1D-E9E5-4D48-A426-0F1FE82F4442Q54216786-02A78CBE-BB00-4AC0-A95E-D2ED74371D27
P2860
Infectious molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Infectious molecular clone of ...... ce of intraclade recombination
@ast
Infectious molecular clone of ...... ce of intraclade recombination
@en
type
label
Infectious molecular clone of ...... ce of intraclade recombination
@ast
Infectious molecular clone of ...... ce of intraclade recombination
@en
prefLabel
Infectious molecular clone of ...... ce of intraclade recombination
@ast
Infectious molecular clone of ...... ce of intraclade recombination
@en
P2093
P2860
P1433
P1476
Infectious molecular clone of ...... ce of intraclade recombination
@en
P2093
Agnès-Laurence Chenine
Charles Wood
Ganapati J Bhat
Lan-Yu Yeh
Ricky D Grisson
Ruth M Ruprecht
Weidong Xu
P2860
P304
14066-14069
P356
10.1128/JVI.78.24.14066-14069.2004
P577
2004-12-01T00:00:00Z